# Assessing Bioavailability of CoQ10 Supplementation in Burn Patients

> **NCT02251626** · EARLY_PHASE1 · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Burn Injury

## Interventions

- **DIETARY_SUPPLEMENT:** coenzyme Q10
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT02251626
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2017-04
- **Final completion:** 2017-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-09-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02251626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02251626, "Assessing Bioavailability of CoQ10 Supplementation in Burn Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02251626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*